Abstract
Infection with influenza A virus represents a major public health threat worldwide, particularly m patients with asthma However, immunity induced by influenza A virus may have beneficial effects, particularly in young children, that might protect against the later development of asthma, as suggested by the hygiene hypothesis Herein, we show that infection of suckling mice with influenza A virus protected the mice as adults against allergen-induced airway hyperreactivity (AHR), a cardinal feature of asthma The protective effect was associated with the preferential expansion of CD4(-)CD8(-), but not CD4(+), NKT cells and required T-bet and TLR7 Adoptive transfer of this ell population into allergen-sensitized adult mice suppressed the development of allergen-induced AHR, an effect associated with expansion of the allergen-specific forkhead box p3(+) (Foxp3(+)) Treg cell population Influenza-induced protection was mimicked by treating suckling mice with a glycolipid derived from Helicobacter pylon (a bacterium associated with protection against asthma) that activated NKT cells in a CD1d restricted fashion These findings suggest what we believe to be a novel pathway that can regulate AHR, and a new therapeutic strategy (treatment with glycolipid activators of this NKT cell population) for asthma
Original language | English |
---|---|
Pages (from-to) | 57-69 |
Number of pages | 13 |
Journal | Journal of Clinical Investigation |
Volume | 121 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2011 |